Georgia's Online Cancer Information Center

Andrew Pippas

Andrew W. Pippas, MD

Board Chairman

Director of Clinical Oncology Research

Piedmont Columbus Regional - John B. Amos Cancer Center

Andrew W. Pippas, MD

Andrew Pippas

Board Chairman

Director of Clinical Oncology Research

Piedmont Columbus Regional - John B. Amos Cancer Center

Dr. Andrew Pippas is medical director and director of clinical oncology research with the John B. Amos Cancer Center at Piedmont Columbus Regional in Columbus, Georgia. Dr. Pippas' research interests include gastrointestinal malignancies. A 2010 Distinguished Georgia Cancer Scholar, he a recipient of the National Institutes of Health's Physician Scientist Award. Dr. Pippas is board certified in Internal Medicine, Hematology, and Medical Oncology. He earned his Doctor of Medicine from the University of Utah School of Medicine in Salt Lake City, and completed his residency in internal medicine and a fellowship in medical oncology/ hematology at the Duke University Medical Center in Durham, North Carolina. He is an active member of the American Society of Clinical Oncology and the American Society of Hematology.

About Us

Georgia CORE announces the first annual Phillip H. Street Cancer Community Service Award and the 2023 Matt Mumber M.D. Award for Excellence in Cancer

After a months-long nomination and selection process, Georgia CORE is pleased to announce Tiah Tomlin-Harris the winner of the first award given in honor of the late Phillip Street. Together with CPNG, Georgia CORE also has awarded the 2023 Matt Mumber M.D. Award for Excellence in Cancer Patient Navigation to Emily Beard of Northside Hospital

12/06/2022

Looking Across Disciplines to Share the Breadth of Innovation in Cancer Care

On July 25, 2023, The American Journal of Managed Care® brought its Institute for Value-Based Medicine (IVBM) series to Atlanta, Georgia, where nnovation was on the agenda.

8/22/2023

DNA sequencing can lead to longer, better lives for cancer patients. But why do so few get it?

Guidelines now call for everyone diagnosed with advanced lung and colon cancer to get their tumor genetically sequenced, and increasingly, patients with earlier stage disease, as well.

6/09/2023

Georgia CORE releases report from Disparities in Cancer Clinical Trials Summit

On Sept. 30, Georgia's cancer experts shared advice and experiences with oncology providers, patient navigators and research managers - all to provide new ways to diversify participation in clinical trials. In February 2023, Georgia CORE issued a report with a recap and actions steps. Download the report >>

10/25/2022

Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofit that leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.